Grantclosed🌐 United StatesPAR-25-261

NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional)

National Institutes of Health

Details?

Posted: Nov 21, 2024
Response deadline: Aug 15, 2025, 12:00 AM UTC
Type: Grant
Category: 93.279
Status: closed
Buyer: National Institutes of Health
Department: HHS-NIH11
Jurisdiction: United States
Reference #: PAR-25-261

Doc Type: synopsis
Opp Status: archived

Similar past solicitations

Avenir Award Program for Research on Substance Use Disorders and HIV (DP2 Clinical Trial Optional)
United States · Mar 10, 2023
Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)
United States · Oct 21, 2022
Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed)
United States · Oct 20, 2022
Dynamic and Adaptable Infrastructure for Drug Development and Outreach to Aid the Research Community in Advancing Medication Repurposing and Repositioning Efforts for Substance Use Disorders (SUDs) (U54 - Clinical Trials Not Allowed)
United States · Sep 24, 2025
Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
United States · Jan 3, 2025
Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
United States · Jan 3, 2025

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.